Salmonella typhi

BIOLOGICAL3 trials

Sponsors

University of Oxford, Finlay Institute

Conditions

Paratyphoid FeverTyphoid Fevertyphoid fever

Phase 2

Clinical trial to evaluate the safety, reactogenicity and immunogenicity of the vax-TyVi vaccine in volunteers between 18 and 20 years of age.

Active, not recruitingRPCEC00000056

Finlay Institutetyphoid fever

Start: 2002-01-09Updated: 2026-09-14

A phase I/II study to evaluate the Salmonella Typhi Vi polysaccharide vaccine – vax-TyVi – in children and teenagers.

Active, not recruitingRPCEC00000055

Finlay Institutetyphoid fever

Start: 2002-02-12Updated: 2026-09-14

Unknown Phase

Investigating Enteric Fever - Salmonella Typhi and Paratyphi Challenge Study

CompletedNCT02192008

University of OxfordParatyphoid Fever, Typhoid Fever

Start: 2014-12-31End: 2022-05-26Updated: 2022-06-02

Related Papers

Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model

PLoS neglected tropical diseases2020-10-2038 citations

Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model

PLoS neglected tropical diseases2019-12-2636 citations